太美医疗科技 02576Stock Information

Stock Information · Old Rules
// Company Overview //
Stock Name太美医疗科技
Stock Code02576
Company Full Name太美医疗科技
Industry軟件服務
Principal Activities公司是中國醫藥及醫療器械研發和營銷領域最大的數字化解決方案供應商,為醫藥及醫療器械行業的產業鏈各方設計并提供專業的軟件及數字化服務。
Listing Date2024-10-08
Listing Rules EraOld Rules
Listing Rules ChapterNo data
Weighted Voting Rights (WVR)No
Registered Address (Mainland China)中國浙江省嘉興市昌盛南路36號智慧產業創新園9號樓3樓
Business Address (Hong Kong)No data
Place of IncorporationNo data
Listing MethodNo data
Listing BoardMain Board
Websitehttps://www.taimei.com/
Share Registrar卓佳证券登记有限公司 (Tricor Investor Services Limited)
Registrar Contact(852)2862 8628
A-Share/US Dual ListingNo data
// Offering Information //
Offering Mechanism 机制B
Clawback Tiers机制B不设回拨,公开发售占比维持50.0%
Prospectus Date2024-09-27
Offer PriceHK$ 13.00 / shares
Offer Price RangeFinal offer price only, no range
Lot Size200 shares
Entry ThresholdHK$ 2,600
Par ValueNo data
Global Offering Shares25,779,000
HK Public Offering Shares12,889,600 (50.0%)
International Placing Shares— (0.0%)
Offer RatioNo data
Total Shares Post-IPONo data
Total Global Offering SizeHK$ 335,127,000
Public Offering SizeHK$ 167,564,800 (50.0%)
Oversubscription Multiple27.2x
Valid Applications25,455
Accepted Applications7,799
ReallocationNo
Total Funds RaisedHK$ 167,564,800
Greenshoe (Over-allotment Option)No data
Final Public Offering Share50.0%
// Valuation & Financials //
Market Cap (at Offer Price)HK$ 0
Pre-IPO Valuation (Last Round)No data
P/E Ratio-19.17
Profit/Loss StatusNo data
Period-End Cash BalanceNo data
Listing Expenses~HK$ 75,600,000
Listing Expenses / Funds RaisedNo data
Total Pre-IPO InvestmentNo data
// First Day Performance
First Day CloseLoading...
First Day OpenHK$ 11.24
First Day Change-29.23%
First Day Volume16319600.0
First Day Turnover171030000.0
// Price Chart //
Loading...
// Use of Proceeds
Use of Proceeds1、約35%或65.0百萬港元將用于優化并升級TrialOS平臺及PharmaOS平臺及其 各自的云端軟件及數字化服務; 2、約30%或約55.7百萬港元將用于提升核心技術及研發能力; 3、約10%或18.6百萬港元將用于強化銷售及營銷能力; 4、約15%或27.9百萬港元將用于選擇性地尋求認為將能擴充現有產品及服務品類、擴大客戶基礎及提升技術能力的戰略投資及收購; 5、約10%或18.6百萬港元將用作營運資金及一般企業用途。
// Underwriting Syndicate //
联席保荐人 (2)
摩根士丹利亚洲有限公司 中国国际金融香港证券有限公司
整体协调人 (2)
摩根士丹利亚洲有限公司 中国国际金融香港证券有限公司
联席账簿管理人 (8)
摩根士丹利亚洲有限公司 中国国际金融香港证券有限公司 华泰金融控股(香港)有限公司 招银国际融资有限公司 建银国际金融有限公司 富途证券国际(香港)有限公司 老虎证券(香港)环球有限公司 华盛资本证券有限公司
联席牵头经办人 (8)
摩根士丹利亚洲有限公司 中国国际金融香港证券有限公司 华泰金融控股(香港)有限公司 招银国际融资有限公司 建银国际金融有限公司 富途证券国际(香港)有限公司 老虎证券(香港)环球有限公司 华盛资本证券有限公司
// Cornerstone Investors //
This stock has no cornerstone investors.
// Directors & Management //
Chairman趙璐
Company Secretary倪曉梅,潘秉揚
No director data available.
// Major Shareholders //
Major Shareholders & Holdings趙璐(16.60%),林芝騰訊投資管理有限公司(10.01%),經緯創騰(杭州)創業投資合伙企業(有限合伙)(9.00%)
// Allotment Benchmarks //
Pool A (Small Subscriptions)
Shares AppliedApplicantsAllotteesExpected Lots
200 9,549 257 0.03
400 1,694 91 0.05
600 1,533 123 0.08
800 797 85 0.11
1,000 1,438 191 0.13
1,200 259 41 0.16
1,400 197 36 0.18
1,600 294 61 0.21
1,800 150 34 0.23
2,000 1,403 353 0.25
3,000 1,690 638 0.38
4,000 585 294 0.50
5,000 393 246 0.62
6,000 268 201 0.75
7,000 452 395 0.88
8,000 284 284 1.00
9,000 104 13 1.12
10,000 1,047 261 1.25
20,000 904 452 2.50
30,000 380 285 3.75
40,000 378 364 4.96
50,000 203 41 6.20
60,000 156 69 7.44
70,000 91 62 8.68
80,000 226 208 9.92
90,000 55 9 11.16
100,000 282 113 12.40
150,000 147 89 18.60
200,000 164 132 24.80
250,000 46 46 31.00
300,000 37 8 37.20
350,000 63 30 43.40
Pool B (Large Subscriptions)
Shares AppliedApplicantsAllotteesExpected Lots
400,000 133 94 140.80
450,000 4 1 158.18
500,000 11 8 175.75
600,000 13 11 210.90
700,000 7 7 246.05
800,000 3 3 281.20
900,000 1 1 315.90
1,000,000 4 4 350.00
1,120,800 10 2 392.28
Allotment Benchmarks
Disclaimer & Risk Warning

Site Nature: This website (cibo.qizai.ai) is an independent technology product showcase platform established by Panda Securities Limited (CE Number: BNC380). This website itself and all content displayed herein do not constitute and are not involved in any regulated activity or licensed service.

Not Investment Advice: The data on this page is automatically extracted from prospectus PDFs by AI and may contain omissions or errors. Some data is supplemented from HKEX New Listing Reports ([HKEX]). All information and data on this page are sourced from prospectuses and related historical documents, are not real-time data, and will not be automatically updated, reflecting historical information at the time of prospectus publication. All content is provided solely for AI tool analysis learning exchange and technical reference purposes, and absolutely does not constitute any investment advice, offer to buy or sell, solicitation, recommendation, or guarantee. The output of this AI analysis tool should not be interpreted as investment opinion.

Decision Responsibility: Users should make investment decisions based on their own independent judgment and consult independent licensed financial advisors when needed. Neither the Company nor this AI analysis tool shall bear any responsibility for any investment decisions made by users based on the information on this page.

Separation from Panda Securities Official Website: The content of this website is strictly distinct from the SFC-regulated licensed services provided by Panda Securities' official website (fafa.hk). No securities trading or account opening or other regulated operations can be conducted through this website.

Panda Securities Limited is a licensed corporation regulated by the Hong Kong SFC (CE Number: BNC380) and a Hong Kong Exchange Participant (Participant ID: 02229). Use of this website constitutes acceptance of this disclaimer.

Cibo — IPO & Market Data Analytics